.- The
Grünenthal laboratory, which manufactures the morning-after pill in
Chile, has decided to pull the drug from the market because of poor
sales and the constant legal challenges being made by pro-life groups
who denounce the drug’s abortifacient nature.
Pro-life
leaders, represented by Fernanda Otero, applauded the decision, saying
it “proves that [the drug] induces an abortion.” “Life must
always be protected,” she said, adding she was sure the drug was going
to be pulled because nobody can guarantee that it “does not kill the
unborn.”
On the other
side, Veronica Schiappacasse, a researcher at the Chilean Institute of
Reproductive Medicine and a fervent supporter of the drug, said the
decision by Grünenthal was “troubling and understandable.” “I
suppose they had no intention of continuing to manufacture it as it was
not good business.”
Schiappacasse
said she would now look to the new government led by President Michelle
Bachelet “to create policies in favor of women’s rights and not be
pressured by minority groups that want to control the rights of
Chileans.”
Poor sales force laboratory to pull morning-after pill from Chilean market
Related news
Related articles
Feb
12
Liturgical Calendar
February 12, 2012
Sixth Sunday in Ordinary TimeAll readings:
Today »This year »
Featured Videos
 |
World Youth Day organizers unveil Brazilian-themed logo for 2013 |
 |
"World Youth Day - Rio 2013" Logo Release |
 |
Eduardo Verastegui at Lighthouse Pregnancy Center Fundraiser |
Catholic Daily
Daily Readings
First Reading:: Lev 13:1-2, 44-46Psalm:: Ps 32:1-2, 5, 11Second Reading:: 1 Cor 10:31-11:1Gospel:: Mk 1:40-45
Most Popular
